Who is sponsoring NCT04617977?

NCT04617977 is sponsored by The University of Hong Kong.

What drugs are being tested in NCT04617977?

Interventions in NCT04617977: I-BMS for families with children suffering from eczema, Health education for parents whose children have eczema.

What condition does NCT04617977 study?

NCT04617977 studies Eczema, Dermatitis, Atopic.

Is NCT04617977 still recruiting?

NCT04617977 is currently status unknown. Last updated 27 January 2022.

Last reviewed 2022-01-27 · How we verify

NCT04617977

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Integrative Body-Mind-Spirit Intervention for Families With Children Suffering From Eczema

Status unknown NA Last updated 27 January 2022

What this trial tests

NA trial testing I-BMS for families with children suffering from eczema in Eczema in 192 participants. Status unknown.

Timeline

23 August 2021

Primary endpoint
31 October 2023

31 December 2023

Quick facts

Lead sponsor	The University of Hong Kong
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	192
Start date	23 August 2021
Primary completion	31 October 2023
Estimated completion	31 December 2023
Sites	1 location across Hong Kong

Drugs / interventions tested

I-BMS for families with children suffering from eczema
Health education for parents whose children have eczema

Conditions studied

Eczema — all drugs for Eczema →
Dermatitis, Atopic — all drugs for Dermatitis, Atopic →

Sponsor

The University of Hong Kong

Who can join

Adults 6 to 100, any sex, with Eczema or Dermatitis, Atopic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aims to examine the efficacy of two integrative body-mind-spirit interventions, compared to a health education active control, in promoting adaptive emotional regulation and quality of life of children with eczema and their parent caregivers in Hong Kong. It also aims to examine the interdependent associations between children and their parent caregivers' baseline primary outcomes and the post-intervention changes in primary outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of the integrative Body-Mind-Spirit group intervention for improving quality of life in parent-child dyads adjusting to atopic dermatitis: protocol for a randomised controlled trial.
Hui VKY, Chan CHY, Fung YL, Chan CLW, et al · · 2022 · cited 1× · PMID 35296490 · DOI 10.1136/bmjopen-2021-059150

Verify or expand the search:

Other recruiting trials for Eczema

Currently open trials in the same condition.

NCT07463079 — Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema · NA · recruiting
NCT06807268 — A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema · Phase 3 · recruiting
NCT07355075 — A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis) · Phase 2 · recruiting
NCT06998446 — Sodium in the Skin and Atopic Dermatitis · recruiting
NCT06994520 — Efficacy of Topical Cannabidiol for Eczema · Phase 2 · active not recruiting

Other The University of Hong Kong trials

Trials by the same sponsor.

NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04617977 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
Last refreshed: 27 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04617977.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing